StockData
LeMaitre Vascular Inc logo

LeMaitre Vascular Inc (LMAT) stock

LMATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3022% below fair value
$76.10−0.91 (-1.18%)

Close on Nov 17, 2026Market cap $1.74BP/E 26.7Yield 1.05%

LeMaitre Vascular price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

LeMaitre Vascular's price to sales ratio was 6.9× on Nov 11, 2026, against 8.0× a year earlier. Over the last 5 years it ranged from 5.9× to 11.4×, with a median of 8.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20266.9×−0.9
2025Dec 31, 20257.8×−2.0
2024Dec 31, 20249.8×+3.0
2023Dec 29, 20236.8×+0.5
2022Dec 30, 20226.4×−0.6
2021Dec 31, 20216.9×+0.2
2020Dec 31, 20206.8×+0.5
2019Dec 31, 20196.3×+1.7
2018Dec 31, 20184.6×−1.8
2017Dec 29, 20176.5×+0.9
2016Dec 30, 20165.6×+1.5
2015Dec 31, 20154.1×+2.3
2014Dec 31, 20141.8×−0.4
2013Dec 31, 20132.2×+0.6
2012Dec 31, 20121.6×−0.0
2011Dec 30, 20111.6×−0.5
2010Dec 31, 20102.1×–

More LeMaitre Vascular figures

See a number that looks wrong?